Findings from a nationwide, multicenter study led by Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health suggest that patients with COVID-19 have less chance of developing ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Fewer patients with COVID-19-induced ARDS who received ...

High-titre convalescent plasma therapy given within a week of symptom onset reduced hospitalisation and death and was well tolerated in immunocompromised patients with mild COVID-19. This randomised ...

Stephen Garcia’s family is frantic. The auto body worker, just 32 years old, has been on a ventilator in a Los Angeles-area hospital for nearly two weeks, gravely ill with COVID-19, unresponsive — and ...

Using advanced research techniques, including a form of artificial intelligence, a team of researchers has discovered unique patterns of blood plasma proteins in patients with suspected long COVID ...

Joyner is a professor in the Department of Anesthesiology and Perioperative Medicine at the Mayo Clinic and led the U.S. Expanded Access Program for Convalescent Plasma. Wright is a professor of ...

GENEVA: The World Health Organization on Monday advised against using the blood plasma of patients who have recovered from COVID-19 to treat those who are ill, saying current evidence shows it neither ...

With the surge in the proportion of COVID-19 patients, the United States Food and Drug Administration is facilitating access to coronavirus convalescent plasma to treat patients with serious or fatal ...

A research team led by MedUni Vienna has shown in a study that purely optical measurements of the viscosity of blood plasma may provide information about the severity and progression of COVID-19. The ...

Researchers discover that COVID-19 mRNA vaccines do not generate long-lasting plasma cells in the bone marrow, shedding light on why antibody immunity wanes quickly, and highlighting the urgent need ...